ライフサイエンスコーパス: hospitalization

1 gardless of location (ie, prior to or during hospitalization).

2 vents was 495 669 per year (48% unrelated to hospitalization).

3 s delayed feeding (</=48 vs. >48 hours after hospitalization).

4 ntilation for at least the first 48 hours of hospitalization.

5 death, stroke, major bleeding, and all-cause hospitalization.

6 gy testing affected clinical outcomes during hospitalization.

7 d with cognitive impairment during and after hospitalization.

8 steroids, and severe events by the need for hospitalization.

9 t was not associated with any other cause of hospitalization.

10 (20.26%) STCUL were ordered after 3 days of hospitalization.

11 vision, Clinical Modification codes for each hospitalization.

12 ents in all-cause mortality or heart failure hospitalization.

13 and elective procedures requiring inpatient hospitalization.

14 w the oral microbiome responds to short-term hospitalization.

15 and it is reversible over the first week of hospitalization.

16 ximately 14% of the ICC patients died during hospitalization.

17 h December 31, 2011, and followed up through hospitalization.

18 infection at the same site as initial sepsis hospitalization.

19 n and at 30 days, 6 months, and 1 year after hospitalization.

20 mase-producing Enterobacteriaceae during ICU-hospitalization.

21 s susceptible to dysbiosis during short-term hospitalization.

22 same site and organism as the initial sepsis hospitalization.

23 m a single U.S. health system, through their hospitalization.

24 use of smartphone-based geofencing to track hospitalizations.

25 leading cause of pediatric bronchiolitis and hospitalizations.

26 uitous, have not been leveraged to ascertain hospitalizations.

27 y underestimate true effects for respiratory hospitalizations.

28 ntially burdensome transitions of care after hospitalizations.

29 of asthma outpatient visits, ED visits, and hospitalizations.

30 n result in emergency dialysis and avoidable hospitalizations.

31 r since cultures were negative in one of the hospitalizations.

32 creased risk of asthma-related ED visits and hospitalizations.

33 fidence interval, 1.09-1.81]; odds ratio>/=2 hospitalization, 1.36 [95% confidence interval, 1.04-1.7

34 interval], 26.80 [18.76 to 38.29]), previous hospitalization (12.42 [8.85 to 17.43]), previous antimi

35 Of the 229 patients who died during their hospitalization, 149 (65.0%) had sepsis or septic shock

36 d ratio=3.42, 95% CI=2.21-5.28), but not for hospitalization 3.5 years or more after examination (haz

37 41.5% vs 43.1%), fractures (11.3% vs 18.6%), hospitalization (47.6% vs 42.3%), and antibiotic-treated

38 During the index hospitalization, 825 (21.8%) underwent splenectomy, 293

39 Moreover, LT/HV patients had shorter hospitalizations (9 vs 12 days, P < 0.01) and lower 30-d

40 years, 712 (8%) individuals had a first COPD hospitalization, 964 (11%) a first respiratory-related a

41 However, the risk of hospitalization (adjusted hazard ratio, 1.34; 95% confid

42 g the association of Medicaid expansion with hospitalization after injury is vital in the disposition

43 ilable on the etiology of diarrhea requiring hospitalization after rotavirus vaccine introduction in

44 7 to 0.75), total mortality or heart failure hospitalization (aHR: 0.32; 95% CI: 0.12 to 0.82), and t

45 djusted vaccine effectiveness for preventing hospitalization among infants with pertussis was 72% (95

46 eneficiaries in the study, there were 469582 hospitalizations among 457193 patients (204232 women and

47 nary heart disease (CHD) events after sepsis hospitalizations among community-dwelling adults.

48 40%, 46%, and 69% in the number of rotavirus hospitalizations among infants in 2013, 2014, and 2015,

49 267 763 and 276 031 AMI hospitalizations among older and younger patients, respe

50 ad a $7328.91 financial advantage in initial hospitalization and $2241.17 in the 90-day postdischarge

51 (April 2011-May 2013) and interviewed during hospitalization and 1-month post-discharge 1521 nondemen

52 ow state and/or increased volume, transplant hospitalization and 1-year posttransplant outcomes were

53 xposure before age 4 years and no subsequent hospitalization and 159619 matched unexposed control chi

54 icated with patients and families at time of hospitalization and advance directives solicited.

55 Mortality was evaluated during hospitalization and at 30 days, 6 months, and 1 year aft

56 le cell disease (SCD) and a leading cause of hospitalization and death in both children and adults wi

57 th HF dies, their surviving spouse's risk of hospitalization and death increases.

58 An adjudication panel determined ILD hospitalization and death.

59 roportion of patients experiencing 1 or more hospitalization and hospitalization and/or emergency roo

60 tory tract infections are frequent causes of hospitalization and initiation of empirical antimicrobia

61 cal trial, this new drug was found to reduce hospitalization and mortality in systolic heart failure.

62 ersons have the highest influenza-associated hospitalization and mortality rates.

63 eart failure (HF) remains a leading cause of hospitalization and mortality worldwide.

64 attenuation are a novel risk factor for ILD hospitalization and mortality.

65 failure are associated with a high risk for hospitalization and mortality.

66 ty, and AD in adults and examine the risk of hospitalization and suicide.

67 d to severe complications and often requires hospitalization and surgery.

68 nd mortality in burn patients during initial hospitalization and up to 1 year after injury.

69 We sought to compare hospitalization or hospitalization and/or emergency room visit rates in pat

70 s experiencing 1 or more hospitalization and hospitalization and/or emergency room visit, respectivel

71 approximately halved exacerbations requiring hospitalization and/or emergency room visits compared wi

72 achnoid hemorrhage (13.2/10000 to 10.3/10000 hospitalizations and 15.8/10000 to 11.5/10000 hospitaliz

73 9-1.00; P=0.05; I(2)=0%) and composite of HF hospitalizations and all-cause mortality (relative risk,

74 mpact of ezetimibe on cardiovascular-related hospitalizations and associated costs is unknown.

75 year in the United States resulting in more hospitalizations and deaths than any other foodborne bac

76 dels were fitted to population-based data on hospitalizations and deaths.

77 permitted inference on influenza-associated hospitalizations and deaths.

78 To reduce asthma-related hospitalizations and ED visits for Medicaid-insured pedi

79 014 EV-D68 epidemic, high rates of pediatric hospitalizations and ED visits were observed.

80 ry outcome was 30-day mortality rate for all hospitalizations and for 15 common medical and 6 surgica

81 We assessed the associations between sepsis hospitalizations and future acute and fatal CHD events u

82 tatus, were associated with fewer subsequent hospitalizations and lower follow-up costs.

83 ychiatric status, were associated with fewer hospitalizations and lower healthcare costs.

84 ic shock (785.52), as well as all subsequent hospitalizations and sepsis readmissions within 90 days.

85 We classified patients according to hospitalizations and the presence of cardiovascular dise

86 se progression includes composite mortality, hospitalization, and 10% FVC decline.

87 16% (n=237) were cognitively impaired during hospitalization, and 11% (n=174) were impaired 1 month a

88 tory-related and 342 (4%) a first CV-related hospitalization, and 556 (6%) died.

89 Most serious complications led to hospitalization, and most GI complications occurred with

90 causes of death and clinical outcomes during hospitalization, and the effects of such variations on i

91 of life) 3 to 7 days before surgery, during hospitalization, and up to 2 weeks after discharge.

92 cer were hospitalized, 16% had three or more hospitalizations, and 64% of hospitalizations originated

93 hospitals, sepsis was present in 6% of adult hospitalizations, and in contrast to claims-based analys

94 nk score (hierarchy of death, cardiovascular hospitalizations, and percent changes in 6-min walk dist

95 ' history of tuberculosis and HIV infection, hospitalizations, and social networks.

96 ions (including emergency department visits, hospitalizations, and urologic procedures to manage gros

97 78) for major adverse cardiovascular events, hospitalizations, and vascular access thrombosis, respec

98 Such hospitalizations are associated with substantial patient

99 cardiovascular events (death, heart failure, hospitalization, arrhythmia, thromboembolic events, and

100 marathon dates was 28.2% (323 deaths in 1145 hospitalizations) as compared with 24.9% (2757 deaths in

101 on) to test whether the decline in pneumonia hospitalizations associated with vaccine introduction va

102 performed active surveillance for rotavirus hospitalizations at the largest hospital in Zanzibar, Ta

103 There were 48 hospitalizations attributable to ILD (crude rate, 6.4 pe

104 Forty-four of the 52 (84.6%) did not require hospitalization based on ultimate diagnosis, and 48 (92.

105 tially preventable events, and the effect of hospitalization-based prophylaxis are uncertain.

106 ion, and with a threefold increased risk for hospitalization because of infections during the first y

107 advanced cancer who experienced an unplanned hospitalization between September 2014 and March 2016.

108 , 2009, and June 30, 2010, and at least 2 HF hospitalizations between July 1, 2009, and December 31,

109 ere similar for white (92.0 per 1,000 sepsis hospitalizations), black (94.0), and Hispanic (93.5) pat

110 ft loss and mortality during the readmission hospitalization, but also portends a lasting, albeit att

111 Cognitive function is often impaired during hospitalization, but whether this impairment resolves or

112 ended follow-up visits required at least one hospitalization by 2 years of age, and the most common r

113 a day-to-day basis over the full year after hospitalization by sex and how these differences compare

114 ing to duration of HF diagnosis before index hospitalization by using pre-specified cutoffs (0 to 1 m

115 esence of children would reduce LRTI-related hospitalizations by 14.8% in this epidemiological settin

116 meter less than or equal to 10 mum (PM10) on hospitalization, by cause and subpopulation, in the Kath

117 Mobile application-based ascertainment of hospitalizations can be achieved with modest accuracy.

118 related to the primary composite outcome (HF hospitalization, cardiovascular mortality, or aborted ca

119 at, RV-A and RV-C are the dominant causes of hospitalization category infections in young children, e

120 for severe acute respiratory illness (SARI) hospitalization conducted in South Africa during Februar

121 an usual care and was associated with higher hospitalization costs across a broad range of patient an

122 and Quality (AHRQ) for 2010 to calculate the hospitalization costs per year attributed to misdiagnose

123 included 1-year survival, organ support, and hospitalization costs.

124 Hospitalization data from 2003 to 2012 were used to iden

125 Routinely collected primary care and hospitalization datasets are useful resources to estimat

126 ased by 75%, and median number of unintended hospitalization days fell by 31%.

127 d, the rate of inpatient mortality during AF hospitalization decreased by 4% per year, and the rate o

128 ital primary care practices), asthma-related hospitalizations decreased from 8.1 (95% CI, 7.7-8.5) to

129 We used linked primary care, hospitalization, disease registry, and mortality data in

130 iome; however, we also found that short-term hospitalization does not impact the richness or structur

131 analysis of an all-payer database recording hospitalizations during 2013 in the United States (Natio

132 Hospitalizations during a 24-month observation period we

133 a accounts for excess cardiovascular-related hospitalizations, especially in the elderly.

134 on HD patients who experienced an infectious hospitalization event within 60 days (HD+) (n = 12), vs.

135 etween Little Schmidy scores and patient and hospitalization factors were examined using multilevel m

136 psychotic symptoms was associated with later hospitalization for a nonaffective psychotic disorder.

137 come inequality affects use of resources per hospitalization for ACSCs.

138 roke, hospitalization for heart failure, and hospitalization for acute coronary syndrome, and the inc

139 of health vulnerability following inpatient hospitalization for acute illness.

140 Adjusted rates of hospitalization for AF increased by approximately 1% per

141 een 1999 and 2013, and we evaluated rates of hospitalization for AF, in-hospital mortality, length of

142 luded major bleeding, blood transfusion, and hospitalization for bleeding.

143 disease, -21.7 (95% CI, -37.1 to -6.4); and hospitalization for cardiovascular disease, -45.7 (95% C

144 tors, and causes of 30-day readmission after hospitalization for CLI.

145 Hospitalization for deliberate self-harm in bariatric pa

146 Hospitalization for depression before surgery and major

147 increased risk of post-surgery self-harm and hospitalization for depression is mainly attributable to

148 Timely follow-up after hospitalization for heart failure (HF) is recommended.

149 was 5.2% and 25.8%, respectively, and repeat hospitalization for heart failure at 1 year occurred in

150 ardial infarction, fatal or nonfatal stroke, hospitalization for heart failure, and hospitalization f

151 ated with lower risk of all-cause mortality, hospitalization for heart failure, and major adverse car

152 use mortality, cardiovascular mortality, and hospitalization for HF.

153 5% CI: 0.12 to 0.82), and total mortality or hospitalization for major adverse cardiac events (aHR: 0

154 dy was a time-dependent composite outcome of hospitalization for management of decompensated heart fa

155 The use of high-intensity statins following hospitalization for MI increased progressively from 2011

156 rdiac events defined as all-cause mortality, hospitalization for myocardial infarction, ischemic stro

157 ty was associated with an increased risk for hospitalization for nonaffective psychotic disorder with

158 oms alone are not useful in predicting later hospitalization for nonaffective psychotic disorder.

159 Direct cost of the hospitalization for primary resection and total direct c

160 d 5-23 months, the VE of 2 RV1 doses against hospitalization for rotavirus diarrhea was 57% (95% conf

161 omes were emergency department (ED) visit or hospitalization for skin and soft-tissue infection (SSTI

162 antibiotics were provided in 10654 of 14480 hospitalizations for ACS (73.6%).

163 Efforts aimed at reducing rates of hospitalizations for ACSCs should consider focusing on a

164 : 0.88 to 0.91; p < 0.0001) and increases in hospitalizations for AF/supraventricular tachycardia (HR

165 From 2004 to 2013, sepsis hospitalizations for all racial/ethnic groups increased,

166 We sought to estimate changes in hospitalizations for all-cause pneumonia associated with

167 controls, we found a substantial decline in hospitalizations for all-cause pneumonia in infants in a

168 Observed numbers of first hospitalizations for cerebrovascular events were compare

169 identified 1 392 289, 530 771, and 1 125 231 hospitalizations for heart failure, acute myocardial inf

170 In 2008 through 2014, 2962554 hospitalizations for HF, 1229939 for AMI, and 2544530 fo

171 Perioperative MACCE occurs in 1 of every 33 hospitalizations for noncardiac surgery.

172 All hospitalizations for STEMI in the United States from Jan

173 ematically evaluated for the incidence of HF hospitalization from study enrollment through 2014.

174 m the identified predictors and validated in hospitalizations from 2012 to 2013 (n=821).

175 low- or moderate-intensity statins prior to hospitalization (from 27.8% to 62.3% in MarketScan and f

176 During the readmission hospitalization, graft loss was substantially higher (de

177 Increasing trends in stroke incidence and hospitalizations have been noted among younger adults, b

178 with a 24% per year higher rate of mortality/hospitalization (hazard ratio [HR]: 1.53; 95% confidence

179 d with GC care had a higher risk of bleeding hospitalization (hazard ratio=1.21; P=0.021) but a simil

180 centration below 15 million/mL and all-cause hospitalizations (hazard ratio = 1.5, 95% confidence int

181 between digoxin and increased mortality and hospitalizations; however, other studies have demonstrat

182 -1.19; P = 0.528) or non-respiratory-related hospitalization (HR, 1.32; 95% CI, 0.92-1.88; P = 0.145)

183 ndpoint (HR: 2.21; 95% CI: 1.80 to 2.71), HF hospitalization (HR: 2.11; 95% CI: 1.58 to 2.81), stroke

184 atory tract infection (LRTI) commonly causes hospitalization in adults.

185 Rate ratios of hospitalization in early childhood until 5 years of age.

186 ted with subsequent death and cardiovascular hospitalization in HFpEF and HFrEF.

187 ct of outpatient NAI treatment on subsequent hospitalization in patients with A(H1N1)pdm09 virus infe

188 for subsequent cardiovascular death/first HF hospitalization in patients with HFpEF and HFrEF, respec

189 he reference period, the risk of ED visit or hospitalization in the 0- to 12-month postsurgery period

190 Hospitalization in the 90 days pre-LT was inversely asso

191 among the most common and costly reasons for hospitalization in the United States.

192 Retrospective cohort study including 14480 hospitalizations in 7178 children (age 0-22 years) with

193 nza was significantly associated with excess hospitalizations in elderly persons aged >/=80 years, wi

194 including a 20% representative sample of all hospitalizations in the United States.

195 ciated with seizure prevalence; frequency of hospitalizations, inability to walk, bradykinesia, scoli

196 s significantly associated with child asthma hospitalizations independent of human rhinovirus infecti

197 ristics (costs, emergency department visits, hospitalizations, intensive care unit admissions, and ch

198 ents waitlisted for a deceased-donor kidney, hospitalization is associated with a lower likelihood of

199 decompensated heart failure (ADHF) requiring hospitalization is associated with high postdischarge mo

200 The effect of pirfenidone on death after hospitalization is uncertain.

201 Ascertainment of hospitalizations is critical to assess quality of care a

202 h heart failure does not reduce mortality or hospitalizations, less is known about its effect on heal

203 All hospitalizations (May 15, 2013 to May 14, 2015) with a p

204 imary and secondary outcomes were transplant hospitalization mortality and 1-year mortality.

205 Transplant hospitalization mortality was 0% for those with mPAP of

206 was 6.4+/-7.3 days with a mean+/-SD cost of hospitalization of $595+/-$1160 USD per admission.

207 s compared with 24.9% (2757 deaths in 11,074 hospitalizations) on nonmarathon dates (absolute risk di

208 iastolic function and were at low risk of HF hospitalization or death (1%/y over a mean 1.7-year foll

209 ssociated with a greater risk of incident HF hospitalization or death at a median follow-up of 608 da

210 -brain natriuretic peptide and subsequent HF hospitalization or death.

211 .07) but no significant increases in repeat hospitalization or dialysis.

212 Major bleeding, defined as hospitalization or emergency department visit with a pri

213 days, and a history of a prior HF event (HF hospitalization or equivalent) to either an NT-proBNP-gu

214 We sought to compare hospitalization or hospitalization and/or emergency room

215 particularly serious infections resulting in hospitalization or surgical treatment, were associated w

216 ut do not lead to psychiatric consultations, hospitalization, or suicide.

217 d three or more hospitalizations, and 64% of hospitalizations originated in the emergency department.

218 r suspected A(H1N1)pdm09 and at high risk of hospitalization, outpatient or community-based NAI treat

219 ower risk of nonelective respiratory-related hospitalization over the course of 1 year.

220 h, myocardial infarction, or unstable angina hospitalizations over a median follow-up of 26.1 months.

221 and digoxin use for mortality (P=0.4437) and hospitalization (P=0.7122).

222 Symptom burden and anxiety during HCT hospitalization partially mediated the effect of the int

223 nced multiple emergency department visits or hospitalizations, particularly those requiring admission

224 mated hospitalization rates as the number of hospitalizations per 100 person-years for all causes, AI

225 This system identified direct costs of hospitalization, physician fees, laboratory tests, invas

226 a hospital with short vs long postoperative hospitalization practices, characterized according to LO

227 ac magnetic resonance performed during index hospitalization provides better prognostic stratificatio

228 0) to examine the association between annual hospitalization rate and a variety of demographic, clini

229 day-30 all-cause mortality or heart failure hospitalization rate differed between the 2 groups.

230 rly persons aged >/=80 years, with an excess hospitalization rate per 100,000 person-years of 242.7 f

231 This study assesses hospitalization rates among people with HIV/AIDS in New

232 We estimated hospitalization rates as the number of hospitalizations

233 associated with a reduction in pediatric AHT hospitalization rates but was associated with self-repor

234 aily cardiovascular- and respiratory-related hospitalization rates constructed from Medicare National

235 Hospitalization rates for AD or eczema were highest in t

236 influence of income inequality on pediatric hospitalization rates for ambulatory care-sensitive cond

237 ssed HMPV in Norwegian children and compared hospitalization rates for HMPV and respiratory syncytial

238 Finally, hospitalization rates for intracerebral hemorrhage and s

239 National HF hospitalization rates have decreased steadily during the

240 are as follows: first, acute ischemic stroke hospitalization rates increased significantly for both m

241 Hospitalization rates of PP decreased from 53.6 to 23.3

242 Annual pneumococcal pneumonia hospitalization rates per 100 000 admissions with 95% co

243 ousehold income and state of residence, ACSC hospitalization rates per 10000 children increased signi

244 ning illness and non-AIDS-defining infection hospitalization rates were 1.3 and 7.2 per 100 person-ye

245 Age group-specific hospitalization rates were consistently higher for women

246 Higher all-cause hospitalization rates were observed among females (46.8

247 [95% confidence interval, 11% to 18%] higher hospitalization rates, respectively, than did men of res

248 om the general population using standardized hospitalization ratios (SHRs) and absolute excess risks

249 es through 7 to 9 weeks, including overnight hospitalization, recurrent skin infections, and similar

250 sure-guided management has become a focus of hospitalization reduction in heart failure.

251 Hospitalizations related to invasive MRSA remained large

252 Rates of heart failure hospitalization remain unacceptably high.

253 After hospitalization, remote-site invasive systemic infection

254 ospitalizations and 15.8/10000 to 11.5/10000 hospitalizations, respectively).

255 years for episodes involving primary care or hospitalizations, respectively.

256 However, the high prevalence of hospitalization resulted in total inpatient costs of $8,

257 t major adverse cardiovascular events and HF hospitalization risk.

258 discharge inpatient resource use data (e.g., hospitalizations, skilled nursing, and rehabilitation fa

259 =inotropes at HT (OR, 1.7; 95% CI, 1.2-2.5), hospitalization status at HT (OR, 1.5; 95% CI, 1.0-2.19)

260 n visits, for a total of 5 in-person visits, hospitalization surveillance, telephone calls, and repea

261 iated with lower risk of respiratory-related hospitalization than placebo (7% vs. 12%; hazard ratio [

262 reserved over time for PHN and HZ-associated hospitalizations than for community HZ.

263 treatment, as well as 2-year risk of death, hospitalization, thromboembolic events, heart failure (H

264 er of US VTE events related and unrelated to hospitalization using Rochester Epidemiology Project res

265 ine of risk, that is, during the readmission hospitalization versus periods postreadmission, will pro

266 e of all-cause death was 36%, and rate of HF hospitalization was 27%.

267 te of the composite of all-cause death or HF hospitalization was 48%, rate of all-cause death was 36%

268 e fully adjusted model, VE against influenza hospitalization was 58.0% (95% confidence interval [CI],

269 protein requirements during the first 3 d of hospitalization was associated with a shorter LOS of 4.4

270 Longer duration of ventilator usage and hospitalization was associated with increased feelings o

271 orbidity, and a significantly higher risk of hospitalization was found, in particular for cardiovascu

272 Although the likelihood of dying during hospitalization was greater among patients treated in de

273 al that is free from death and heart failure hospitalization was higher for adherent patients than fo

274 years of age, and the most common reason for hospitalization was lower respiratory tract infection (L

275 visit for asthma within 30 days of an index hospitalization was reduced from 12% to 7%.

276 age, the median percentage reduction in AGE hospitalizations was 38% overall and 41%, 30%, and 46% i

277 uartile range) number of inpatient admission hospitalizations was 4 (2-8), with 114 patients (83%) re

278 The cumulative incidence of hospitalizations was 65.4%, ranging from 60.5% in those

279 The incidence of ALRI hospitalizations was similar in the IIV and placebo grou

280 d not receive angiography during their first hospitalization were balanced on 44 covariates of propen

281 ay to 1-year all-cause mortality, and repeat hospitalization were compared.

282 r pelvic injuries, and those who died during hospitalization were excluded.

283 ommon clinical features at triage and during hospitalization were fever, weakness, anorexia, and diar

284 ary and November 2013 who survived the index hospitalization were identified in the Nationwide Readmi

285 l course, and complications during and after hospitalization were reviewed for each patient, and esti

286 Acute stroke hospitalizations were identified by the principal Intern

287 relatively rare, non-AIDS-defining infection hospitalizations were more common.

288 osite endpoint (cardiovascular mortality and hospitalization) were evaluated in 842 T2DM patients fro

289 , medication costs) and utilization (visits, hospitalizations) were compared between patients with an

290 ost (including readmission/ileostomy closure hospitalizations) were significantly greater in the RS g

291 ardial infarction, stroke, and heart failure hospitalization, were compared between patients who adhe

292 0% and the GWTG risk score identified 20% of hospitalizations where 180-day postdischarge mortality w

293 variables were significantly associated with hospitalization while waitlisted, suggesting that person

294 ct advanced chronic kidney disease following hospitalization with acute kidney injury.

295 A total of 179,810 survivors of hospitalization with AMI without HF or LVSD, between Jan

296 sons was associated with a higher VE against hospitalization with influenza than vaccination in eithe

297 All adult hospitalizations with a diagnosis code for CLI were incl

298 rovements in both survival and heart failure hospitalizations with CRT-D were greatest in patients wi

299 Study entry required hospitalization within the previous 36 h, active dyspnea

300 osite end point of all-cause mortality or HF hospitalization without significantly increasing the cha